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Cohort profile
AbstrACt
Purpose Centenarians, a segment of the population which 
some 50 years ago comprised only a few individuals, now 
count thousands in many countries, and demographic 
projections forecast that this growth will continue. The 
study of this new population will give us new information 
on extreme longevity and help prepare for their health 
and social needs. The aim of the Centenari a Trieste 
study is to describe the health and health service use by 
centenarians, with specific focus on cognitive status.
Participants This is a population-based study of 
centenarians living in the province of Trieste (Italy), a small 
area with a high prevalence of centenarians and a close 
network of health and social services, which makes it 
possible to conduct a study. Consenting individuals were 
visited by a clinician, tested by neuropsychologists and 
also gave a sample of their blood. Administrative data were 
retrieved as well.
Findings to date Of the 163 centenarians, 70 could be 
contacted and participated in the study. The main reasons 
for non-participation were impossibility to contact the 
subject (70) and death (20). Centenarians were mostly 
women (90%), tended to live in a nursing home (60%) 
and were generally severely functionally impaired (Barthel 
Index <50: 61%). Data from the administrative database 
showed that about one out of five needed hospitalisation in 
the preceding year and more than three out of four had at 
least one drug prescription.
Future plans In 2017, we started a new wave of the 
study enrolling people who had just become centenarian 
and reassessing subjects already seen; we hope to extend 
this recruitment in the next years. Subjects are now 
examined also by cardiologists and dental specialists. We 
are collecting further different biological specimens to 
investigate new hypotheses on the cognitive function of 
the centenarians.
IntroduCtIon 
The numbers and percentages of older 
people are dramatically growing in most parts 
of the world and people aged 90 years old 
and older, termed ‘oldest old’, are the fastest 
growing group. Compared with younger 
people, the oldest old have more functional 
variability and these differences contribute 
to the complexity of understanding their 
clinical and cognitive status. Furthermore, 
because of the small number of centenar-
ians in the past decades and the difficulties 
of studying them, despite the large number 
of studies on older people younger than 85 
years old very few population-based studies 
have focused on centenarians until now,1 
and even fewer population-based studies 
included a neuropathological examination.2 
Most studies on centenarians present under-
standable limitations. The first is the difficulty 
in recruiting centenarians, so most studies 
have enrolled only small numbers, often scat-
tered over large, widely differing areas. The 
strengths and limitations of this study
 ► The major strength of the study lies in it being a 
population-based study, where all centenarians are 
invited to participate, and no exclusion criterion is 
used.
 ► In order to build a comprehensive picture of 
the centenarians, we included in the first wave 
neuropsychological testing, clinical examinations, 
blood drawing and administrative data access and 
enhanced the procedure in the second wave adding 
different medical disciplines and procedures such 
as ECG, echocardiography, and saliva and faeces 
collection.
 ► The study benefits from the close network of 
collaboration with the centenarians’ families, nursing 
homes, social services, general practitioners, and 
biological and clinical researchers.
 ► The complex procedure of the enrolment in the 
first wave of the study caused a low response rate 
among the centenarians, which we are trying to 
overcome in the second wave.
 ► We could not verify the age of the individuals, which 
is an important piece of information in studies 
on centenarians; however, we found an almost 
perfect concordance between the data from the 
city demographic offices and those from the Italian 
National Institute of Statistics.
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second is related to testing cognitive abilities, because 
many centenarians are almost deaf and have visual and 
movement impairment3 4; then too, in the oldest old, the 
criteria for a diagnosis of dementia pose intrinsic difficul-
ties and there is a lack of consensus on ‘how’ and ‘when’ 
making a dementia diagnosis.5 Centenarians often lack 
brain imaging and neuropathological examinations are 
rare. For all these reasons our knowledge of centenarians, 
and specifically of their cognitive status, is still limited and 
hazy.
Centenarians have been studied using two approaches. 
The main studies, such as the Georgia Centenarian Study,6 
New England Centenarian Study,7 90+ Study8 and others, 
have very wide catchment areas in order to recruit a large 
number of centenarians, but at the cost of having a popu-
lation who do not share genetic traits, food, religion and 
lifestyle habits. Other studies are limited to small regions 
where the populations present specific characteristics. 
These areas, called ‘Blue Zones’ (BZs), are limited areas 
with a high prevalence of centenarians, with rather homo-
geneous characteristics, lifestyles and environments.9 The 
BZs identified so far are in Okinawa (Japan),10 on the 
Nicoya peninsula11 (Costa Rica), on the island of Ikaria12 
(Greece) and in Ogliastra (Sardinia, Italy).9
The numbers of centenarians are rapidly increasing 
worldwide and so are the studies on this segment of the 
population, advancing the knowledge acquired so far. In 
Italy, where the number of centenarians rose from 150 
in the mid-1950s to approximately 20 000 in 2014, there 
are several population studies on the oldest old.13 14 The 
Centenari a Trieste (CaT) or Centenarians in Trieste 
study started in 2014 and is currently ongoing. It is a 
population-based study on centenarians living in the 
province of Trieste, an Italian city where the prevalence 
of centenarians is very high: 7 per 10 000 inhabitants 
against 3 per 10 000 in Italy as a whole.15 Trieste, with just 
over 200 000 inhabitants, is located in the north-east of 
Italy, on the border with Slovenia, overlooking the Adri-
atic Sea. The demographic structure of Trieste is unusual, 
because the city has always been influenced by its location 
at the crossroads of Latin, Slavic and Germanic cultures. 
Until the end of the First World War, when Trieste was 
part of the Austro-Hungarian Empire, the city was one 
of the most important Mediterranean seaports and many 
people with different habits and religions moved there 
from different parts of Europe for their business. For 
this reason, although small like a BZ, Trieste is a sort of 
ethnic melting pot and a centenarian study is interesting 
and special. Furthermore, the small area and the close 
network between health and social services make the 
study easier to manage.
Aims of the Cat study
The objective of the study is to describe the health status 
of a population of centenarians, measuring disease and 
disability prevalence, use of social and health services, 
and present and past lifestyles. It is particularly inter-
esting to quantify cognitive impairment, because of its 
high prevalence and its consequences at the personal 
and societal levels. Investigations will also concentrate 
on correlations between these variables and genetic and 
biological characteristics.
Cohort desCrIPtIon
study population
On 1 January 2014, the Province of Trieste was inhabited 
by approximately 236 000 individuals, of whom 87% lived 
in Trieste city. In Italy, all inhabitants are cared for by the 
National Health System, organised, on a regional basis, 
in autonomous local health authorities (LHAs), which 
usually correspond to the provinces, as in our case. The 
study population comprised all subjects born before 1914 
and registered on 1 January 2014, with the Trieste LHA 
(ASS1 or Azienda Servizi Sanitari 1 Triestina, now ASUITS 
or Azienda Sanitaria Universitaria Integrata di Trieste).
study design
After obtaining the list of the centenarians cared for by 
the Trieste LHA, we sent a request to the LHA profes-
sionals already in contact with the centenarians and their 
families (general practitioner (GP), nursing home or 
community service personnel) asking them to allow us to 
explain the study to the centenarians and their families 
for their enrolment. After receiving consent to the study 
presentation (first informed consent), one of us (GM) 
went to the centenarian’s residence (home or institute) 
to describe the study procedures. If the person was willing 
to participate in the study, we obtained a second signed 
informed consent for enrolment and possibly a third 
signed informed consent for a blood sample.
The examination involved two visits: (1) a clinical visit 
to collect data on present and past pathologies and on 
daily living activities; (2) a neuropsychological assessment 
during which the patients were tested using an ad hoc 
battery on cognitive and mood domains. At a subse-
quent visit, a blood sample was obtained from the subset 
of consenting centenarians by one of us (GM) together 
with a registered nurse. The samples were immediately 
processed in the laboratory for lymphocyte cell isolation 
and DNA extraction. Subsequently all parts of the sample 
were stocked at −80°C.
In some cases, data from the centenarians were obtained 
interviewing an informant: a relative, a close friend or 
personnel of the institute where the subject lived. Further 
information on present and past health of the centenar-
ians enrolled was extracted from the LHA administrative 
databases.
Interviews were conducted between January 2014 and 
July 2015.
Clinical evaluation: personal history and neurological 
examination
The clinical evaluation was done by one of us (GM, 
neurologist) and involved obtaining information using 
a standardised questionnaire on family history and 
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sociodemographic data, present and past lifestyles, life-
time eating habits, currently taken drugs, surgical inter-
ventions, hospitalisations or access to the emergency 
room (ER), hearing and vision impairment and need for 
assistance or supervision. Information on present and 
past pathologies (cardiovascular, central nervous system 
and diabetes) with related therapies was recorded. A 
second part of the clinical evaluation was the physical 
examination.
diagnosis of dementia
The neurologist and the neuropsychologists inde-
pendently made a tentative diagnosis of dementia 
applying the criteria of Diagnostic and Statistical Manual 
of Mental Disorders—fourth edition.16 In some cases, 
we had difficulty in assessing the presence of dementia 
due to sensory impairment or fatigue which prevented us 
from having a complete picture of the cognitive status of 
the centenarian.
scales and tests
An important part of the visits was devoted to adminis-
tering neuropsychological tests or assessing the person’s 
daily living activities and quality of life or anxiety/depres-
sion using validated structured questionnaires, adminis-
tered in a specific sequence. Subjects were interviewed at 
their place of residence.
Neuropsychological testing
Subjects were tested using the Italian version17 of the 
Mini-Mental State Examination18 (MMSE), a brief 
screening instrument commonly used in epidemiolog-
ical studies to assess cognitive status. In cases with severe 
dementia, a similar but much less demanding test, the 
Severe MMSE,19 was used.
A series of seven tests taken from the Consortium to 
Establish a Registry on Alzheimer’s Dementia (CERAD)20 
battery was then tried: Verbal Fluency (animal catego-
ries), Boston Naming Test (15 items), Word List Memory, 
Word List Recall and Word List Recognition, Construc-
tional Praxis and Recall of Constructional Praxis. This 
battery was translated into Italian by the laboratory to 
which one (MT) of us is affiliated, and was validated in 
elderly native Italian speakers.21
Three other specific tests were used: the Visual Search 
on Matrices of Digits,22 the forward and backward Digit 
Span test23 and the Prose Memory test.22
After the tests, the Informant Questionnaire on Cogni-
tive Decline in the Elderly (IQCODE)24 25 was adminis-
tered to an informant. The IQCODE assesses change in 
the cognitive function of the subject. Change was assessed 
relative to 10 years ago and, whenever possible, also 40 
years ago.
Mood and quality of life
Depression symptoms were assessed using the 15-item 
version26 of the Geriatric Depression Scale,27 a rating 
scale specifically developed to test elderly people. Anxiety 
was tested with the Beck Anxiety Inventory.28
Quality of life was assessed using the Short Form-12,29 a 
brief questionnaire composed of 12 items, derived from a 
larger 36-item questionnaire.30
The scales were usually administered by or compiled 
under the supervision of the neuropsychologist, rather 
than being self-administered, on account of visual or 
motor impairments. Answers given by subjects with severe 
cognitive impairment were not considered reliable, and 
therefore not used.
Activities of daily living
Independence in daily living tasks was assessed in three 
hierarchically related domains.
The lowest domain, pertaining to the simplest tasks, 
that is, the basic activities of daily living (BADL), was 
assessed using the Barthel Index.31
The Instrumental Activities of Daily Living32 (IADL) 
was used to characterise subjects at a higher level than the 
BADL. This instrument assesses competence in common 
tasks requiring interaction with instruments or media. 
Scores were normalised so that both men and women had 
a possible range between 0 (completely dependent) and 
100 (completely independent).
At the highest level, we gathered data on Advanced 
Activities of Daily Living (AADL) using a modification 
of the questionnaire developed by Verghese et al33 inves-
tigating participation in leisure activities. In addition to 
frequency of present activities, whenever possible we also 
recorded (from an informant) the frequency of the activ-
ities approximately 40 years ago (ie, around retirement 
age).
Administrative data
Italy has universal health insurance, and all contacts 
between citizens and health service providers are recorded 
for administrative purposes (mainly for direct payment 
and cost governance). For the centenarians in our study, 
we had access to the following datasets: hospitalisations 
(dates of hospital admission and discharge, ICD-9-CM34 
diagnostic codes at discharge and procedures during 
hospitalisation, life status at discharge), ER admissions 
(date, text summary relative to the event), drug prescrip-
tions (name of drug, date of dispensation, number of 
boxes, Anatomical Therapeutic Chemical (ATC) classi-
fication35), specialty visits (general type of visit, date of 
visit). We also had access to the same data, anonymised, 
for subjects we could not trace in person. Data were avail-
able from 2000 to 2014.
General practitioners
GPs caring for the centenarians were contacted to 
complete a questionnaire on disease presence, the 
Cumulative Illness Rating Scale,36 and a form on drug 
prescriptions.
Participants
On 1 January 2014, there were 163 centenarians in the 
Trieste LHA, 21 (13%) men and 142 (87%) women. Most 
of the centenarians were born in the Province of Trieste 
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(42%), in the other provinces of the Friuli-Venezia Giulia 
Region (15%) or in the nearby territories now part of 
Slovenia or Croatia (23%). The rest were born in other 
parts of Italy (17%) or abroad (3%).
Seventy subjects were visited by one of us (GM) and 
for most of them another visit was done by a neuropsy-
chologist (see figure 1 for the flow chart of the study). 
Ninety-three subjects did not participate in the study: for 
most of them (70 subjects, 75%) we could not find an 
LHA professional who was willing or had time to intro-
duce us to the centenarian, while 20 (22%) died between 
prevalence day and the day in which we tried to contact 
them, one refused and two did not participate because 
the relatives thought the visit could bother the cente-
narian. Sex ratio and age were only slightly different 
between participating and non-participating subjects (χ2 
and Mann-Whitney U test, P>0.17) (data for non-partici-
pating subjects retrieved anonymously from administra-
tive database).
The main characteristics of the participating and 
non-participating subjects are reported in tables 1 and 2.
statistical analysis
Numeric variables were summarised using means and SDs 
when the distribution of the variable was approximately 
symmetrical or medians when it was skewed or in presence 
of outliers. Numeric variables were dichotomised when 
the resulting clinical meaning was clearer (eg, IADL). 
Ordinal variables were dichotomised to avoid having 
classes with very few or no individuals (eg, AADL). Differ-
ences between participants and non-participants were 
Figure 1 Flow chart of the study.
Table 1 Main sociodemographic characteristics of the 
participating subjects (n=70)
n (%) Available data
Age (mean±SD) 102.1±1.9 70
Sex 70
  Males 7 (10%)
  Females 63 (90%)
Native Italian speakers 49 (78%) 63
Living condition 66
  Institutionalised 40 (60%)
  Living alone 5 (8%)
  Living with others 21 (32%)
Years of education: mean 
(SD)
6.3 (2.6) 65
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tested using χ2 (nominal variables) or Mann-Whitney 
U test (numeric variables).
FIndInGs to dAte
Participating subjects
In many cases (74%), the information received from the 
centenarian was supplemented by data from an infor-
mant. Mean age of the informant was 69.6 years, with a 
majority of females (81%). In almost half of the cases (24 
subjects), the informant was a daughter. When the subject 
was institutionalised and no relatives could be traced or 
when the centenarian was living alone (26%), we did not 
have an informant.
The mean (SD) number of chronic drugs was 2.9 (2.2), 
with a moderately high prevalence (24%) of polytherapy 
(five or more drugs). Subjects not using any drug were 
23% of the population. The most prevalent drug classes 
were antithrombotic agents, ATC B01 (40%), and drugs 
for acid-related disorders, mainly proton pump inhibi-
tors (PPIs), ATC A02 (37%), followed by cardiovascular 
system drugs (diuretics, ATC C03 (31%), cardiac therapy, 
ATC C01 (30%), agents acting on the renin–angiotensin 
system, ATC C09 (26%)) and psycholeptics (mainly 
benzodiazepines) ATC N05 (21%). All other drug cate-
gories were used by less than 10% of the centenarians.
The majority of centenarians had significant hearing 
problems (60 subjects, 86%) or seeing (54 subjects, 76%) 
or both (47 subjects, 67%). A sizeable minority (16%) was 
completely deaf, but only one was totally blind.
Most centenarians were severely or completely function-
ally impaired even at the basic stage of the BADLs (Barthel 
Index <50: 61%), while three (5%) were completely 
independent. At a hierarchically higher level, 80% of 
the centenarians have IADL residual ability lower than 
50% and only one was completely independent (missing 
data: BADL 6 subjects, IADL 11 subjects). Due to physical 
and cognitive limitations leisure activities involved only 
a small percentage of subjects. Watching television was 
still a very popular, although highly passive, activity (60% 
watched television at least two times per week), followed 
by listening to music (44%), reading newspapers/maga-
zine (37%) and walking (31%). Among those still taking 
a walk, the median time was relatively limited (15 min/
day). A couple of subjects still walked 2 hours/day. No 
other activity was performed at least two times per week 
by 20% or more of the centenarians (missing data: 35 
subjects—information unavailable for subjects without 
neuropsychological examination or missing informant).
A neuropsychological test session was possible only in 
51 subjects (73%) (five died before the neuropsycholo-
gist could contact the centenarian, three had a relative 
who felt the neuropsychological examination could 
bother the centenarian, one was very sick, six could not 
be tested because of administrative reasons and four 
were not tested since the subject was in a severe/terminal 
dementia condition: for these four persons a score of zero 
was given in the MMSE—these imputed scores may have 
reduced the mean MMSE score). In the CERAD tests, 
the ones completed by the largest number of subjects 
were the Verbal Fluency test and the Boston Naming Test 
(table 3).
Administrative database information
The availability of the administrative databases in the year 
preceding the cohort selection enabled us to achieve two 
goals: retrieve health service usage for the total cente-
narian population and compare usages by the partici-
pating and non-participating subjects, in order to assess 
differences between the two groups.
Table 2 Age and sex distributions of the non-participating 
subjects (n=93)
n (%) Available data
Age (mean±SD) 101.8±1.7 93
Sex 93
  Males 14 (15%)
  Females 79 (85%)
Table 3 Neuropsychological test results and depression 
and quality of life scores
Test n
Attainable 
range Mean (SD)
MMSE* 45 0–30 11.9 (8.4)
CERAD Verbal Fluency 39 0– 6.3 (3.3)
CERAD Boston Naming 
Test
35 0–15 7.3 (2.9)
CERAD Word List Memory 28 0–10 6.7 (3.5)
CERAD Word List Recall 26 0–10 1.0 (1.2)
CERAD Word List 
Recognition
25 0–10 4.5 (3.3)
CERAD Constructional 
Praxis
30 0–11 4.8 (2.2)
CERAD Recall 
Constructional Praxis
21 0–11 1.1 (2.0)
IQCODE 20 5–0 4.1 (0.6)
Geriatric Depression 
Scale†
15 0–15 5.8 (4.2)
SF-12—physical status† 13 0–100 38.5 (12.3)
SF-12—mental status† 13 0–100 47.4 (9.8)
Tests were reported if they were completed by at least 20 
centenarians.
*Contains data from MMSE, data derived from SMMSE and zeros 
for subjects with severe or terminal dementia.
†Only for subjects judged by the neurologist as not having 
dementia.
CERAD, Consortium to Establish a Registry on Alzheimer’s 
Dementia; IQCODE, Informant Questionnaire on Cognitive Decline 
in the Elderly; MMSE, Mini-Mental State Examination; SF-12, 12-
item Short-Form questionnaire; SMMSE, Severe Mini-Mental State 
Examination.
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Almost one out of three (31%) centenarians had at least 
one ER admission, with a higher incidence, not statisti-
cally significant, in the participating subjects (χ2, P=0.29) 
(figure 2A). During these admissions, the mean number 
of services activated (eg, ECG, specialty visit, catheterisa-
tion, etc) was 3.6 (SD 2.9), with no difference between 
the two groups (Mann-Whitney U test, P=0.72).
Similarly, 36 centenarians (22%) had been hospital-
ised in the year preceding the prevalence day, 17 (24%) 
in the participant group and 19 (20%) in the non-par-
ticipant group. Among those hospitalised, the median 
number of days in hospital was 8.5, similar for partici-
pants (8 days) and non-participants (9 days). Diseases of 
the vascular, respiratory and digestive systems were the 
main primary reasons for hospitalisation (33 cases, 62% 
in the whole population, 68% of participants, 57% of 
non-participants).
A high proportion of centenarians (61 subjects, 37%) 
had laboratory tests in 2013, with similar numbers for 
participants (29 subjects, 41%) and non-participants 
(32 subjects, 34%), while a substantial minority needed 
a specialty visit (total: 28 subjects, 17%, 10 participants, 
14%, 18 non-participants, 19%). Of these 60% (33 
subjects) had a cardiologic visit or an eye examination.
Finally, the numbers of drugs (different therapeutic 
subgroups) taken in 2013 were very similar for partici-
pants and non-participants (respective means and SDs 
3.7±2.9 and 3.2±3.1, figure 2B). Since the time window 
encompasses an entire year, unlike data collected directly 
from the centenarian, antibacterials for systemic use, 
ATC J01, were highly prevalent (39%), while ATC A02 
(46%), B01 (36%) and C03 (21%) drug use remained 
high. Two other cardiovascular classes (cardiac therapy, 
ATC C01 (25%) and agents acting on the renin–angio-
tensin system, ATC C09 (26%)), and analgesics, ATC N02 
(21%) were the only other therapeutical subclasses with a 
prevalence of use over 20%. None of the reported differ-
ences between participants and non-participants related 
to administrative data reached 0.05 for significance, 
suggesting that participants’ characteristics were similar 
to those of the whole population.
dIsCussIon
The CaT study was designed in 2013 to investigate the 
clinical, biological and social characteristics of centenar-
ians living in Trieste.
Our centenarians tended to live in nursing home/shel-
tered houses (60%) similarly to centenarians in North 
European and American countries, such as Denmark37 
(59%) and Georgia (USA38) (56%), although there are 
also opposite findings, as in Portugal39 (29%), South 
Korea40 (7%) and Japan (Tokyo41) (32%). The Italian 
Multicenter Study on Centenarians (IMUSCE) results42 
found that only 34% of centenarians lived in a nursing 
home. The difference is probably due to at least two 
factors: the first is a difference between the south of Italy 
(where most of the IMUSCE centenarians lived) where it 
is more likely that, for cultural and economical reasons, 
old people continue to live at home with their close 
relatives than in north of Italy (CaT Study); the second 
reason is a cohort effect, for attitudes towards keeping 
old relatives at home have rapidly shifted (IMUSCE was 
carried out in the mid-1990s). Similarly, at the level of 
education, 33% of IMUSCE participants were illiterate, 
against a 2% in CaT. Worldwide situations also differed 
widely, from South Korea40 (illiterate: 91%) to USA,38 
where subjects with less than 5 years of schooling were a 
small minority (5%, while 30% had more than 13 years 
of schooling).
Figure 2 Health service use by participating and non-participating centenarians. (A) Service use prevalence (%). (B) Number of 
prescribed drugs.
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Chronic drug therapy was highly prevalent (77%) and 
similar to that one reported from a UK GP database43 
(73%), but lower than in two Italian44 45 (90% and 95%) 
and one Danish46 (95%) population studies, and substan-
tially higher than in an administrative database study 
conducted in France47 (44%). Since specific guidelines 
are widely shared for all the diseases highly prevalent in 
the elderly, we expected the pharmacological subclasses 
used in our study to be similar to those reported by 
others; in fact, the studies that reported drug use by ther-
apeutical subclasses did give similar results, though with 
some interesting differences: Australian Veterans48 had 
generally slightly higher drug use, the Danish popula-
tion46 had lower antithrombotic and PPI use, Ontario49 
had higher diuretic and antidepressant and lower PPI 
use and Swedish population50 had higher analgesic and 
benzodiazepine and lower PPI use.
Since we looked at pharmacological therapies from 
two different points of view (day prevalence, at place of 
residence and year prevalence from administrative data-
bases), we found two interesting differences: benzodiaz-
epines were absent from administrative databases, since 
they are not reimbursed in Italy, but were present at 
place of residence, while antibacterials had been widely 
prescribed in the previous year, but were not being used 
at the time of the visit. Except for Australian veterans, PPI 
use was lower in the other studies. High PPI use, with a 
large proportion of inappropriate use,51 has been already 
reported in elderly Italian patients,52 in both primary and 
secondary care.
When looking at health services, we need to consider 
that both the state of health of the population and the 
national legislative/financial regulations for treatment 
possibilities contribute to their use. However, our data on 
use of services (ER 31% and hospital admissions (H) 22%) 
are similar to the ones reported elsewhere: Ontario49 (ER 
26.6%, H 18.2%), UK53 (H 41.5%, in the year following 
the prevalence day), Denmark37 (H 56.5% in 5 years) and 
Veterans in Australia48 (H 19.1%), while the number of ER 
admissions was much lower than in the USA54 (73.6%). 
Such great use of expensive services may have a profound 
impact on the sustainability of the health services, in view 
of the fast rise in the absolute numbers of centenarians. 
However, this gloomy future is tempered by the fact that the 
high costs are for a substantial part related to the proximity 
of death,55 so they are inescapable and are currently high 
among centenarians because of their very high mortality. 
It will be interesting to compare present and future service 
use rates to see if they shift with changes in mortality.
We also found that centenarians in Trieste had a very 
high degree of disability, as others have found.37 40 56 57 
This requires a lot of assistance but, like for service use, 
Arai et al58 and Christensen et al56 demonstrated that even 
in extreme age disability is more prevalent in subjects who 
have the shortest life expectancy, so these results must be 
interpreted more from a dynamic than a static point of 
view, comparing results from different cohorts examined 
longitudinally.
ForthComInG wAve oF vIsIts
In April 2017, we began a second wave of visits on the 
subjects who became centenarians after 2014 and to the 
centenarians included in the first wave. We also revised the 
tests and scales in the neuropsychological battery after a 
preliminary analysis of their completion rates, excluding 
tests that proved too hard to administer for cognitive or 
sensory impairment or for logistic difficulties. A digital 
recorder is being used to assess spoken language. Since 
two clinics of the department of medical sciences (dental 
medicine and cardiology) are now collaborating with us, 
the study was expanded to look closely at those specific 
characteristics in the centenarians and identify any link 
with dementia. A cardiologist makes a complete cardi-
ologic visit, including echocardiogram, ECG and heart 
rate variability. A dentist does an objective examination 
of the oral cavity with oral mucosa brushing for biolog-
ical studies. At the same time the diagnoses of dementia 
tentatively made in the first wave are being reappraised 
with the help of a third independent examiner to reach 
a consensus on the presence of the disease. The severity 
of the disease will be scored using the Clinical Dementia 
Rating59 staging rules. Results on the data from this forth-
coming wave of visits are presently not available. The 
revised ongoing version of the protocol was presented 
and approved by the Regional Ethics Committee.
strenGths And lImItAtIons
The CaT Study was designed in 2013 to investigate the 
clinical, biological and social characteristics of centenar-
ians living in Trieste. Since this is a study on centenarians, 
a limitation of the study is the absence of a confirmation 
of the age of the individuals, while in other studies on 
centenarians this checking is present. However, we are 
confident that the date of birth reported in the adminis-
trative database is the real date of birth since this database 
is frequently updated using the official data stored in the 
city demographic offices, and the data are in an almost 
perfect concordance with the numbers reported by the 
Italian National Institute of Statistics.
The major strength of the study lies in it being a popu-
lation-based study, where all centenarians are invited to 
participate, and no exclusion criterion is used. The study 
was designed with an open mind towards collaboration: 
in the first wave neurologists, neuropsychologists, biol-
ogists, GPs, data administrators and social workers were 
invited to collaborate. In the second wave, we were joined 
by two new medical disciplines, which will implement 
procedures as ECG, echocardiography, and saliva and 
faeces collection.
The major limitation in the first wave of this study was 
the low response rate among the centenarians, which 
could cast doubt on the generalisability of the results. 
The impossibility of directly asking subjects about their 
willingness to participate in the study, and the consequent 
need to ask persons not directly involved, left us with a 
high percentage of centenarians we could not contact. 
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This contrasts with the willing acceptance shown by 
almost all the centenarians we could approach. However, 
the access to the administrative data allowed us to test if 
the enrolled sample was different from the subjects we 
could not contact: importantly, these supplementary data 
suggest that the sample we could contact is not biased 
since it has very similar features to those of the whole 
population. Moreover, to increase the response rate, we 
are now experimenting new ways to contact the cente-
narians, seeking the cooperation from other health and 
social service professionals.
An important added strength of the new wave of this 
study is the presence of dental medicine and cardiology 
specialists, which will give the study the opportunity to 
assess aspects of the centenarian population with little or 
no publication record.
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